Flagship Ventures Fund IV General Partner’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
$87.2M Buy
+480,666
New +$87.2M 14.92% 3